nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CASP3—ovarian cancer	0.387	0.522	CbGaD
Minocycline—VEGFA—ovarian cancer	0.18	0.243	CbGaD
Minocycline—MMP9—ovarian cancer	0.174	0.235	CbGaD
Minocycline—CASP3—ovarian follicle—ovarian cancer	0.0138	0.136	CbGeAlD
Minocycline—CASP1—myometrium—ovarian cancer	0.00236	0.0233	CbGeAlD
Minocycline—CYCS—embryo—ovarian cancer	0.00218	0.0215	CbGeAlD
Minocycline—CASP3—myometrium—ovarian cancer	0.00194	0.0192	CbGeAlD
Minocycline—CASP3—embryo—ovarian cancer	0.00187	0.0185	CbGeAlD
Minocycline—CASP1—epithelium—ovarian cancer	0.00185	0.0183	CbGeAlD
Minocycline—CASP1—uterine cervix—ovarian cancer	0.00184	0.0181	CbGeAlD
Minocycline—CYCS—epithelium—ovarian cancer	0.00178	0.0176	CbGeAlD
Minocycline—CYCS—uterine cervix—ovarian cancer	0.00177	0.0174	CbGeAlD
Minocycline—CASP1—decidua—ovarian cancer	0.00175	0.0173	CbGeAlD
Minocycline—CASP1—endometrium—ovarian cancer	0.00166	0.0164	CbGeAlD
Minocycline—IL1B—myometrium—ovarian cancer	0.00155	0.0153	CbGeAlD
Minocycline—CASP1—gonad—ovarian cancer	0.00154	0.0152	CbGeAlD
Minocycline—CASP1—uterus—ovarian cancer	0.00153	0.0151	CbGeAlD
Minocycline—VEGFA—myometrium—ovarian cancer	0.00153	0.0151	CbGeAlD
Minocycline—CASP3—epithelium—ovarian cancer	0.00153	0.0151	CbGeAlD
Minocycline—CASP3—uterine cervix—ovarian cancer	0.00151	0.0149	CbGeAlD
Minocycline—IL1B—embryo—ovarian cancer	0.00149	0.0147	CbGeAlD
Minocycline—CYCS—gonad—ovarian cancer	0.00148	0.0146	CbGeAlD
Minocycline—CYCS—uterus—ovarian cancer	0.00147	0.0145	CbGeAlD
Minocycline—CASP3—decidua—ovarian cancer	0.00144	0.0142	CbGeAlD
Minocycline—CASP1—female reproductive system—ovarian cancer	0.00137	0.0136	CbGeAlD
Minocycline—CASP3—endometrium—ovarian cancer	0.00137	0.0135	CbGeAlD
Minocycline—CYCS—female reproductive system—ovarian cancer	0.00132	0.0131	CbGeAlD
Minocycline—CASP1—bone marrow—ovarian cancer	0.0013	0.0128	CbGeAlD
Minocycline—CASP3—gonad—ovarian cancer	0.00127	0.0125	CbGeAlD
Minocycline—CASP3—uterus—ovarian cancer	0.00126	0.0124	CbGeAlD
Minocycline—CASP1—female gonad—ovarian cancer	0.00125	0.0123	CbGeAlD
Minocycline—CYCS—bone marrow—ovarian cancer	0.00125	0.0123	CbGeAlD
Minocycline—MMP9—embryo—ovarian cancer	0.00125	0.0123	CbGeAlD
Minocycline—CASP1—vagina—ovarian cancer	0.00124	0.0123	CbGeAlD
Minocycline—IL1B—epithelium—ovarian cancer	0.00122	0.012	CbGeAlD
Minocycline—CYCS—female gonad—ovarian cancer	0.0012	0.0119	CbGeAlD
Minocycline—VEGFA—uterine cervix—ovarian cancer	0.00119	0.0117	CbGeAlD
Minocycline—IL1B—decidua—ovarian cancer	0.00115	0.0114	CbGeAlD
Minocycline—CASP3—female reproductive system—ovarian cancer	0.00113	0.0112	CbGeAlD
Minocycline—VEGFA—decidua—ovarian cancer	0.00113	0.0112	CbGeAlD
Minocycline—CASP1—testis—ovarian cancer	0.00111	0.011	CbGeAlD
Minocycline—IL1B—endometrium—ovarian cancer	0.00109	0.0108	CbGeAlD
Minocycline—VEGFA—endometrium—ovarian cancer	0.00108	0.0106	CbGeAlD
Minocycline—CASP3—bone marrow—ovarian cancer	0.00107	0.0106	CbGeAlD
Minocycline—CYCS—testis—ovarian cancer	0.00107	0.0105	CbGeAlD
Minocycline—CASP3—female gonad—ovarian cancer	0.00103	0.0102	CbGeAlD
Minocycline—CASP3—vagina—ovarian cancer	0.00103	0.0101	CbGeAlD
Minocycline—MMP9—epithelium—ovarian cancer	0.00102	0.01	CbGeAlD
Minocycline—IL1B—uterus—ovarian cancer	0.00101	0.00994	CbGeAlD
Minocycline—MMP9—uterine cervix—ovarian cancer	0.00101	0.00994	CbGeAlD
Minocycline—VEGFA—uterus—ovarian cancer	0.000991	0.00978	CbGeAlD
Minocycline—MMP9—decidua—ovarian cancer	0.00096	0.00947	CbGeAlD
Minocycline—CASP3—testis—ovarian cancer	0.000915	0.00903	CbGeAlD
Minocycline—MMP9—endometrium—ovarian cancer	0.000911	0.00899	CbGeAlD
Minocycline—IL1B—female reproductive system—ovarian cancer	0.000906	0.00894	CbGeAlD
Minocycline—IL1B—bone marrow—ovarian cancer	0.000855	0.00844	CbGeAlD
Minocycline—VEGFA—bone marrow—ovarian cancer	0.000841	0.0083	CbGeAlD
Minocycline—MMP9—uterus—ovarian cancer	0.00084	0.00829	CbGeAlD
Minocycline—IL1B—female gonad—ovarian cancer	0.000824	0.00813	CbGeAlD
Minocycline—IL1B—vagina—ovarian cancer	0.000819	0.00808	CbGeAlD
Minocycline—VEGFA—female gonad—ovarian cancer	0.000811	0.008	CbGeAlD
Minocycline—VEGFA—vagina—ovarian cancer	0.000806	0.00795	CbGeAlD
Minocycline—CASP1—lymph node—ovarian cancer	0.000804	0.00794	CbGeAlD
Minocycline—CYCS—lymph node—ovarian cancer	0.000774	0.00764	CbGeAlD
Minocycline—ALOX5—decidua—ovarian cancer	0.000759	0.00749	CbGeAlD
Minocycline—MMP9—female reproductive system—ovarian cancer	0.000755	0.00745	CbGeAlD
Minocycline—IL1B—testis—ovarian cancer	0.000731	0.00721	CbGeAlD
Minocycline—VEGFA—testis—ovarian cancer	0.000719	0.0071	CbGeAlD
Minocycline—SLC22A11—female reproductive system—ovarian cancer	0.000715	0.00706	CbGeAlD
Minocycline—MMP9—bone marrow—ovarian cancer	0.000713	0.00703	CbGeAlD
Minocycline—MMP9—female gonad—ovarian cancer	0.000687	0.00678	CbGeAlD
Minocycline—CASP3—lymph node—ovarian cancer	0.000663	0.00655	CbGeAlD
Minocycline—MMP9—testis—ovarian cancer	0.000609	0.00601	CbGeAlD
Minocycline—ALOX5—female reproductive system—ovarian cancer	0.000597	0.00589	CbGeAlD
Minocycline—SLC22A7—testis—ovarian cancer	0.000564	0.00556	CbGeAlD
Minocycline—ALOX5—bone marrow—ovarian cancer	0.000563	0.00556	CbGeAlD
Minocycline—ALOX5—female gonad—ovarian cancer	0.000543	0.00536	CbGeAlD
Minocycline—IL1B—lymph node—ovarian cancer	0.00053	0.00523	CbGeAlD
Minocycline—VEGFA—lymph node—ovarian cancer	0.000521	0.00514	CbGeAlD
Minocycline—ALOX5—testis—ovarian cancer	0.000482	0.00475	CbGeAlD
Minocycline—MMP9—lymph node—ovarian cancer	0.000442	0.00436	CbGeAlD
Minocycline—ALOX5—lymph node—ovarian cancer	0.000349	0.00345	CbGeAlD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	2.08e-05	0.000132	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HRAS—ovarian cancer	2.08e-05	0.000132	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—ovarian cancer	2.07e-05	0.000132	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PARP1—ovarian cancer	2.06e-05	0.000131	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.06e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PIK3CA—ovarian cancer	2.04e-05	0.00013	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.03e-05	0.000129	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.02e-05	0.000128	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PIK3CA—ovarian cancer	2.01e-05	0.000128	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	2e-05	0.000127	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HDAC6—ovarian cancer	2e-05	0.000127	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CG—ovarian cancer	1.99e-05	0.000127	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—AKT1—ovarian cancer	1.99e-05	0.000127	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—ovarian cancer	1.99e-05	0.000126	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—STAT3—ovarian cancer	1.99e-05	0.000126	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.96e-05	0.000125	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—ovarian cancer	1.96e-05	0.000125	CbGpPWpGaD
Minocycline—CASP1—Immune System—ERBB2—ovarian cancer	1.95e-05	0.000124	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.95e-05	0.000124	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—NRAS—ovarian cancer	1.94e-05	0.000123	CbGpPWpGaD
Minocycline—CASP1—Immune System—MTOR—ovarian cancer	1.92e-05	0.000122	CbGpPWpGaD
Minocycline—CASP1—Immune System—PIK3CB—ovarian cancer	1.92e-05	0.000122	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MAPK3—ovarian cancer	1.9e-05	0.000121	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—ovarian cancer	1.9e-05	0.00012	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—FASN—ovarian cancer	1.89e-05	0.00012	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—HRAS—ovarian cancer	1.89e-05	0.00012	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HRAS—ovarian cancer	1.86e-05	0.000118	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC5A5—ovarian cancer	1.86e-05	0.000118	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MAPK3—ovarian cancer	1.86e-05	0.000118	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CAV1—ovarian cancer	1.82e-05	0.000116	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ERBB2—ovarian cancer	1.82e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.81e-05	0.000115	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDKN1B—ovarian cancer	1.81e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MAPK1—ovarian cancer	1.81e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—ovarian cancer	1.8e-05	0.000114	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC2A1—ovarian cancer	1.8e-05	0.000114	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—ovarian cancer	1.78e-05	0.000113	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—ovarian cancer	1.77e-05	0.000112	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—YAP1—ovarian cancer	1.77e-05	0.000112	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MAPK1—ovarian cancer	1.77e-05	0.000112	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—ovarian cancer	1.76e-05	0.000112	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.76e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CD—ovarian cancer	1.75e-05	0.000111	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HDAC6—ovarian cancer	1.73e-05	0.00011	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—XIAP—ovarian cancer	1.73e-05	0.00011	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP1B1—ovarian cancer	1.72e-05	0.00011	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTNNB1—ovarian cancer	1.71e-05	0.000108	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—ovarian cancer	1.7e-05	0.000108	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMARCA4—ovarian cancer	1.69e-05	0.000107	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—NRAS—ovarian cancer	1.68e-05	0.000107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PPP2R1A—ovarian cancer	1.67e-05	0.000106	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—KRAS—ovarian cancer	1.67e-05	0.000106	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—AKT1—ovarian cancer	1.66e-05	0.000106	CbGpPWpGaD
Minocycline—CASP1—Immune System—PTEN—ovarian cancer	1.66e-05	0.000106	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CG—ovarian cancer	1.66e-05	0.000106	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.66e-05	0.000105	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EREG—ovarian cancer	1.65e-05	0.000105	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—AKT1—ovarian cancer	1.65e-05	0.000105	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6ST—ovarian cancer	1.63e-05	0.000104	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.62e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MAPK3—ovarian cancer	1.61e-05	0.000102	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CTNNB1—ovarian cancer	1.59e-05	0.000101	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ERBB2—ovarian cancer	1.58e-05	0.0001	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PGR—ovarian cancer	1.54e-05	9.8e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—YAP1—ovarian cancer	1.53e-05	9.74e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MAPK1—ovarian cancer	1.53e-05	9.74e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—ovarian cancer	1.53e-05	9.74e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPP2R1A—ovarian cancer	1.53e-05	9.72e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CB—ovarian cancer	1.53e-05	9.7e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.52e-05	9.67e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—ovarian cancer	1.52e-05	9.63e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—XIAP—ovarian cancer	1.5e-05	9.54e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—STAT3—ovarian cancer	1.49e-05	9.45e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—NRAS—ovarian cancer	1.48e-05	9.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.48e-05	9.38e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMARCA4—ovarian cancer	1.46e-05	9.3e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CD—ovarian cancer	1.46e-05	9.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—KRAS—ovarian cancer	1.45e-05	9.2e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDH1—ovarian cancer	1.44e-05	9.18e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PARP1—ovarian cancer	1.43e-05	9.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EREG—ovarian cancer	1.43e-05	9.08e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAPK3—ovarian cancer	1.42e-05	9.03e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCB1—ovarian cancer	1.42e-05	9.03e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—HRAS—ovarian cancer	1.42e-05	9.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—ovarian cancer	1.4e-05	8.91e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—ovarian cancer	1.4e-05	8.89e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TYMS—ovarian cancer	1.39e-05	8.86e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—ovarian cancer	1.39e-05	8.82e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—STAT3—ovarian cancer	1.39e-05	8.81e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NRAS—ovarian cancer	1.38e-05	8.78e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CTNNB1—ovarian cancer	1.38e-05	8.77e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CD—ovarian cancer	1.38e-05	8.77e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—ovarian cancer	1.36e-05	8.62e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—ovarian cancer	1.35e-05	8.6e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAPK1—ovarian cancer	1.35e-05	8.59e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—ovarian cancer	1.35e-05	8.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PGR—ovarian cancer	1.34e-05	8.51e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TERT—ovarian cancer	1.33e-05	8.46e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MAPK3—ovarian cancer	1.32e-05	8.41e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—KRAS—ovarian cancer	1.28e-05	8.11e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CB—ovarian cancer	1.27e-05	8.09e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MAPK1—ovarian cancer	1.26e-05	8.01e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—ovarian cancer	1.26e-05	8e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PARP1—ovarian cancer	1.24e-05	7.91e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CAV1—ovarian cancer	1.23e-05	7.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—HRAS—ovarian cancer	1.23e-05	7.82e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—ERBB2—ovarian cancer	1.22e-05	7.74e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—STAT3—ovarian cancer	1.2e-05	7.64e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CB—ovarian cancer	1.2e-05	7.64e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MTOR—ovarian cancer	1.2e-05	7.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NRAS—ovarian cancer	1.2e-05	7.63e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—KRAS—ovarian cancer	1.19e-05	7.56e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ESR1—ovarian cancer	1.19e-05	7.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—ovarian cancer	1.18e-05	7.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NRAS—ovarian cancer	1.18e-05	7.48e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—PIK3CA—ovarian cancer	1.17e-05	7.45e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6ST—ovarian cancer	1.17e-05	7.41e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PPP2R1A—ovarian cancer	1.16e-05	7.39e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MAPK3—ovarian cancer	1.15e-05	7.3e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1B—ovarian cancer	1.13e-05	7.17e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MAPK3—ovarian cancer	1.13e-05	7.16e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CAV1—ovarian cancer	1.12e-05	7.14e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CG—ovarian cancer	1.12e-05	7.12e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APC—ovarian cancer	1.12e-05	7.12e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—ovarian cancer	1.1e-05	7.02e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTEN—ovarian cancer	1.1e-05	6.99e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MAPK1—ovarian cancer	1.09e-05	6.95e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—ovarian cancer	1.09e-05	6.95e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—HRAS—ovarian cancer	1.09e-05	6.9e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.07e-05	6.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MAPK1—ovarian cancer	1.07e-05	6.82e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTNNB1—ovarian cancer	1.07e-05	6.78e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTEN—ovarian cancer	1.04e-05	6.6e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—ovarian cancer	1.04e-05	6.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—KRAS—ovarian cancer	1.03e-05	6.56e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CG—ovarian cancer	1.02e-05	6.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—KRAS—ovarian cancer	1.01e-05	6.44e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HRAS—ovarian cancer	1.01e-05	6.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PPP2R1A—ovarian cancer	1.01e-05	6.41e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CD—ovarian cancer	9.86e-06	6.26e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—ovarian cancer	9.68e-06	6.15e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—ovarian cancer	9.58e-06	6.09e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CA—ovarian cancer	9.31e-06	5.92e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—STAT3—ovarian cancer	9.29e-06	5.91e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—NRAS—ovarian cancer	9.27e-06	5.89e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TERT—ovarian cancer	9.24e-06	5.87e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—ovarian cancer	9e-06	5.72e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CD—ovarian cancer	9e-06	5.72e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—ovarian cancer	8.93e-06	5.67e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK3—ovarian cancer	8.88e-06	5.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HRAS—ovarian cancer	8.78e-06	5.58e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ERBB2—ovarian cancer	8.7e-06	5.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HRAS—ovarian cancer	8.61e-06	5.47e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CB—ovarian cancer	8.59e-06	5.46e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MTOR—ovarian cancer	8.59e-06	5.46e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CAV1—ovarian cancer	8.54e-06	5.43e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK1—ovarian cancer	8.45e-06	5.37e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—ovarian cancer	8.45e-06	5.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—ovarian cancer	8.4e-06	5.34e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—ovarian cancer	8.25e-06	5.25e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ESR1—ovarian cancer	8.23e-06	5.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6ST—ovarian cancer	8.1e-06	5.15e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1B—ovarian cancer	8.06e-06	5.12e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TERT—ovarian cancer	8.02e-06	5.1e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—KRAS—ovarian cancer	7.98e-06	5.07e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—ovarian cancer	7.89e-06	5.01e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CB—ovarian cancer	7.85e-06	4.99e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APC—ovarian cancer	7.78e-06	4.95e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CG—ovarian cancer	7.78e-06	4.95e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CA—ovarian cancer	7.76e-06	4.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—ovarian cancer	7.75e-06	4.93e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—ovarian cancer	7.69e-06	4.89e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CTNNB1—ovarian cancer	7.62e-06	4.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—ovarian cancer	7.6e-06	4.83e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—ovarian cancer	7.47e-06	4.75e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTEN—ovarian cancer	7.42e-06	4.72e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CAV1—ovarian cancer	7.42e-06	4.71e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CA—ovarian cancer	7.33e-06	4.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ESR1—ovarian cancer	7.15e-06	4.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6ST—ovarian cancer	7.03e-06	4.47e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CD—ovarian cancer	6.84e-06	4.35e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HRAS—ovarian cancer	6.78e-06	4.31e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTEN—ovarian cancer	6.78e-06	4.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CG—ovarian cancer	6.76e-06	4.29e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APC—ovarian cancer	6.76e-06	4.29e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—ovarian cancer	6.7e-06	4.26e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT3—ovarian cancer	6.64e-06	4.22e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NRAS—ovarian cancer	6.62e-06	4.21e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—ovarian cancer	6.49e-06	4.13e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK3—ovarian cancer	6.34e-06	4.03e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—ovarian cancer	6.34e-06	4.03e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—ovarian cancer	6.17e-06	3.92e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ERBB2—ovarian cancer	6.04e-06	3.84e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK1—ovarian cancer	6.03e-06	3.84e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—ovarian cancer	6.03e-06	3.83e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—ovarian cancer	5.99e-06	3.81e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MTOR—ovarian cancer	5.96e-06	3.79e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CB—ovarian cancer	5.96e-06	3.79e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CD—ovarian cancer	5.94e-06	3.77e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—ovarian cancer	5.73e-06	3.64e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KRAS—ovarian cancer	5.7e-06	3.62e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1B—ovarian cancer	5.6e-06	3.56e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CASP3—ovarian cancer	5.48e-06	3.49e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—ovarian cancer	5.48e-06	3.48e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—ovarian cancer	5.34e-06	3.39e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CTNNB1—ovarian cancer	5.29e-06	3.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ERBB2—ovarian cancer	5.25e-06	3.33e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CA—ovarian cancer	5.24e-06	3.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CB—ovarian cancer	5.18e-06	3.29e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MTOR—ovarian cancer	5.18e-06	3.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTEN—ovarian cancer	5.15e-06	3.27e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—ovarian cancer	5.07e-06	3.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—ovarian cancer	4.97e-06	3.16e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1B—ovarian cancer	4.86e-06	3.09e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HRAS—ovarian cancer	4.84e-06	3.08e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CA—ovarian cancer	4.78e-06	3.04e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CASP3—ovarian cancer	4.76e-06	3.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—ovarian cancer	4.75e-06	3.02e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—ovarian cancer	4.65e-06	2.96e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—ovarian cancer	4.64e-06	2.95e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—ovarian cancer	4.63e-06	2.95e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT3—ovarian cancer	4.61e-06	2.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRAS—ovarian cancer	4.6e-06	2.92e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CTNNB1—ovarian cancer	4.59e-06	2.92e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—ovarian cancer	4.5e-06	2.86e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTEN—ovarian cancer	4.47e-06	2.84e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK3—ovarian cancer	4.4e-06	2.8e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—ovarian cancer	4.28e-06	2.72e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—ovarian cancer	4.28e-06	2.72e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK1—ovarian cancer	4.19e-06	2.66e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—ovarian cancer	4.19e-06	2.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT3—ovarian cancer	4e-06	2.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRAS—ovarian cancer	3.99e-06	2.54e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KRAS—ovarian cancer	3.96e-06	2.51e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—ovarian cancer	3.91e-06	2.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK3—ovarian cancer	3.82e-06	2.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—ovarian cancer	3.72e-06	2.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK1—ovarian cancer	3.64e-06	2.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—ovarian cancer	3.64e-06	2.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CA—ovarian cancer	3.64e-06	2.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—ovarian cancer	3.52e-06	2.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KRAS—ovarian cancer	3.43e-06	2.18e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HRAS—ovarian cancer	3.36e-06	2.14e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—ovarian cancer	3.22e-06	2.05e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CA—ovarian cancer	3.16e-06	2.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—ovarian cancer	3.05e-06	1.94e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—ovarian cancer	2.97e-06	1.89e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HRAS—ovarian cancer	2.92e-06	1.86e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—ovarian cancer	2.79e-06	1.78e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—ovarian cancer	2.58e-06	1.64e-05	CbGpPWpGaD
